Mosapride Citrate is used for the treatment of gastritis, gastroesophageal reflux disease, functional dyspepsia and irritable bowel syndrome. It is a gastroprokinetic agent. Reference standards of Mosapride Citrate API,and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
2-Aminomethyl-4-(4-fluorobenzyl)morpholine
Catalogue No.:PA 40 11510
CAS :
Molecular Formula : C12H17FN2O
Molecular Weight : 224.27
Mosapride Citrate
Catalogue No.:PA 40 11000
Molecular Formula : C27H33ClFN3O10
Molecular Weight : 614.02
3-Aminomethyl-4-(4-fluorobenzyl)morpholine
Catalogue No.:PA 40 11520
Mosapride N-Oxide
Catalogue No.:PA 40 11530
Molecular Formula : C21H25ClFN3O4
Molecular Weight : 437.89
N-((4-(3-Fluorobenzyl)morpholin-2-yl)methyl)acetamide
Catalogue No.:PA 40 0111000
Molecular Formula : C14H19FN2O2
Molecular Weight : 266.32
N-((4-Benzylmorpholin-2-yl)methyl)acetamide
Catalogue No.:PA 40 0111001
Molecular Formula : C14H20N2O2
Molecular Weight : 248.33
Mosapride Citric Amide
Catalogue No.:PA 40 0111002
Molecular Formula : C27H31ClFN3O9
Molecular Weight : 596.01
4-Amino-5-bromo-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide
Catalogue No.:PA 40 0111003
Molecular Formula : C21H25BrFN3O3
Molecular Weight : 466.35
(E)-3-((2-Chloro-5-ethoxy-4-(((4-(4-fluorobenzyl)morpholin-2-yl)methyl)carbamoyl)phenyl)carbamoyl)pent-2-enedioic Acid
Catalogue No.:PA 40 0111004
Molecular Formula : C27H29ClFN3O8
Molecular Weight : 577.99
5-Chloro-4-((3,4-dihydroxy-6-(hydroxymethyl)-5-((3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2-yl)amino)-2-ethoxy-N-((4-(4-fluorobenzyl)morpholin-2-yl)methyl)benzamide
Catalogue No.:PA 40 0111005
Molecular Formula : C33H45ClFN3O13
Molecular Weight : 746.18
Methyl 4-acetamido-3,5-dichloro-2-ethoxybenzoate
Catalogue No.:PA 40 0111006
Molecular Formula : C12H13Cl2NO4
Molecular Weight : 306.14
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
